{"id":15262,"date":"2019-05-29T11:17:26","date_gmt":"2019-05-29T11:17:26","guid":{"rendered":"https:\/\/touchneurology.com\/?post_type=media_gallery&p=15262"},"modified":"2022-02-10T14:40:45","modified_gmt":"2022-02-10T14:40:45","slug":"aksel-siva-aan-2019-diagnosis-and-treatment-of-neuro-behcet-disease-part-2","status":"publish","type":"media_gallery","link":"https:\/\/touchneurology.com\/neuromuscular-diseases\/conference-hub\/aksel-siva-aan-2019-diagnosis-and-treatment-of-neuro-behcet-disease-part-2\/","title":{"rendered":"Aksel Siva, AAN 2019 \u2013 Diagnosis and treatment of neuro-Beh\u00e7et disease (Part 2)"},"content":{"rendered":"
US Neurology<\/em> Editorial Board member, Aksel Siva <\/strong>(Istanbul University, Cerrahpa\u015fa School of Medicine, Istanbul, Turkey), discusses latest initiatives in the diagnosis of neuro-Beh\u00e7et disease, a rare and relatively unknown neurological disorder, as well as promising investigational therapies.<\/p>\n <\/p>\n Questions<\/p>\n <\/p>\n\n